Amanote Research
Register
Sign In
Blocking IRF4 Protein Can Eliminate Myeloma Cancer Cells
Expert Review of Proteomics
- United Kingdom
doi 10.1586/14789450.5.4.545
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Molecular Biology
Date
August 1, 2008
Authors
Unknown
Publisher
Informa UK Limited
Related search
Can We Eliminate Trachoma?
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Bone Marrow IRF4 Level in Multiple Myeloma: An Indicator of Peripheral Blood Th17 and Disease
Oncotarget
Oncology
Transcription Factor IRF4 Drives Dendritic Cells to Promote Th2 Differentiation
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
The G-Protein-Coupled Estrogen Receptor Agonist G-1 Suppresses Proliferation of Ovarian Cancer Cells by Blocking Tubulin Polymerization
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
A Global Drive to Eliminate Cervical Cancer
Nature
Multidisciplinary
MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells
Blood
Biochemistry
Immunology
Cell Biology
Hematology
CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells
Molecular Pharmacology
Molecular Medicine
Pharmacology
T(6;14)(p25;q32) IRF4/IGH - T(2;6)(p12;p25) IRF4/IGK - T(6;22)(p25;q11) IRF4/IGL
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus
PLoS ONE
Multidisciplinary